Abstract: Methods are provided for increasing the processivity of DNA polymerases on GC-rich templates. The methods relate to providing enhancers and biased ratios of dNTPs, and may be used in DNA amplification reactions. The methods are useful for detecting genotypes associated with GC-rich repeats, including Fragile X Syndrome.
Abstract: A method for double-stranded DNA purification, by which a solution containing DNA in a mixture with other components is passed over a support on which is covalently coupled an oligonucleotide capable of hybridizing with a specific sequence present on the DNA to form a triple helix.
Type:
Grant
Filed:
August 8, 2011
Date of Patent:
March 19, 2013
Assignee:
Centelion
Inventors:
Joël Crouzet, Daniel Scherman, Pierre Wils, Françis Blanche, Béatrice Cameron
Abstract: The present invention relates to nucleic acid sequencing methods, kits and reagents, and more particularly to methods of sequencing nucleic acid which employ a nucleic acid processing enzyme and one or more nucleotide analogues that are capable of binding to the active site of the enzyme and to complementary bases in the nucleic acid molecule being sequenced, but which are non-incorporable or inhibitors of the nucleic acid processing enzyme. In further aspects, the present invention relates to conjugates which comprise a deoxyribonucleotide triphosphates (DNTPs) or an analogue thereof linked to an intercalating dye.
Abstract: The present invention provides primers and probes to be used in a method of enhancing hybridization of a probe to a target nucleotide sequence when the target sequence is capable of forming intramolecular secondary structures that interfere with hybridization of the probe to the target sequence. In particular, the invention includes a primer for amplifying a target nucleotide sequence, wherein at least a portion of the target nucleotide sequence can form an intramolecular secondary structure. The primer of the invention includes a primer nucleotide sequence complementary to a portion of the target nucleotide sequence that does not form a secondary structure, and a blocking sequence substantially complementary to at least a portion of the secondary structure-forming region of the amplified target nucleotide sequence, wherein the blocking sequence hybridizes to a portion of the secondary structure-forming region of the amplified target nucleotide sequence and blocks the formation of the secondary structure.
Type:
Grant
Filed:
September 15, 2003
Date of Patent:
March 12, 2013
Assignee:
Siemens Healthcare Diagnostics Inc.
Inventors:
Minxue Zheng, John J. Quinn, Brian D. Warner
Abstract: Target-specific hybrid capture (TSHC) provides a nucleic acid detection method that is not only rapid and sensitive, but also highly specific and capable of discriminating highly homologous nucleic acid sequences. The method produces DNA/RNA hybrids which can be detected by a variety of methods.
Type:
Grant
Filed:
November 19, 2009
Date of Patent:
March 5, 2013
Assignee:
Qiagen Gaithersburg, Inc.
Inventors:
James Anthony, Attila Lorincz, Inna Williams, John Troy, Yanlin Tang
Abstract: The present invention provides a composition for selectively delivering an active agent to a portion of an organism. The composition comprises first and second polymer portions, having first and second functional groups attached as a side-chain thereto, respectively. The first and second functional groups form cross-links between the first and second polymer portions. The cross-links are capable of being broken by a substance of the organism, thereby resulting in release of the active agent. The composition provides a novel means for controlling the selective release of the active agent in the organism.
Type:
Grant
Filed:
September 30, 2002
Date of Patent:
March 5, 2013
Assignees:
Alcatel Lucent, Rutgers, The State University of New Jersey
Inventors:
Noshir A. Langrana, David C. Lin, Bernard Yurke
Abstract: The present disclosure relates to methods for efficient synthesis, cloning, transformation and screening of large diverse libraries of polynucleotide variants comprising well-defined nucleotide differences relative to a reference polynucleotide.
Type:
Grant
Filed:
September 18, 2009
Date of Patent:
February 26, 2013
Assignee:
Codexis, Inc.
Inventors:
Jeffrey Colbeck, Benjamin Mijts, Lorraine Joan Giver, Richard J. Fox, Vesna Mitchell, Bumshik Robert Pak, Lynne Gilson
Abstract: Provided herein are optimized methods for performing multiplexed detection of a plurality of sequence variations. Also provided are methods for performing multiplexed amplification of target nucleic acid.
Type:
Grant
Filed:
July 28, 2011
Date of Patent:
January 8, 2013
Assignee:
Sequenom, Inc.
Inventors:
Martin Beaulieu, Dirk Johannes Van Den Boom
Abstract: Nucleic acid sequencing methods and related products are disclosed. Methods for sequencing a target nucleic acid comprise providing a daughter strand produced by a template-directed synthesis, the daughter strand comprising a plurality of subunits coupled in a sequence corresponding to a contiguous nucleotide sequence of all or a portion of the target nucleic acid, wherein the individual subunits comprise a tether, at least one probe or nucleobase residue, and at least one selectively cleavable bond. The selectively cleavable bond(s) is/are cleaved to yield an Xpandomer of a length longer than the plurality of the subunits of the daughter strand, the Xpandomer comprising the tethers and reporter elements for parsing genetic information in a sequence corresponding to the contiguous nucleotide sequence of all or a portion of the target nucleic acid. Reporter elements of the Xpandomer are then detected.
Type:
Grant
Filed:
March 30, 2011
Date of Patent:
January 8, 2013
Assignee:
Stratos Genomics, Inc.
Inventors:
Mark Stamatios Kokoris, Robert N. McRuer
Abstract: An embodiment of a method for detecting low frequency occurrence of one or more HIV sequence variants associated with drug resistance is described that comprises the steps of: generating cDNA species from each RNA molecule in an HIV sample population; amplifying at least one first amplicon from the cDNA species, wherein each first amplicon comprises a plurality of amplified copies and is amplified with a pair of nucleic acid primers that define a locus of the first amplicon; clonally amplifying the amplified copies of the first amplicons to produce a plurality of second amplicons wherein a plurality of the second amplicons comprise an immobilized population of substantially identical copies from one of the amplified copies of first amplicons; determining a nucleic acid sequence composition of the substantially identical copies from at least 100 of the immobilized populations in parallel on a single substrate; and detecting one or more sequence variants that occur at a frequency of 5% or less in the nucleic ac
Type:
Grant
Filed:
December 16, 2010
Date of Patent:
January 1, 2013
Assignee:
454 Life Sciences Corporation
Inventors:
Birgitte Binderup Simen, Elizabeth Patricia St. John
Abstract: The present invention provides a method for amplification of a target nucleic acid sequence or signal, wherein an amplification reaction mixture is used which contains at least one reversibly modified oligonucleotide having a non-hydroxyl group 3? end which can be converted into a hydroxyl 3? end upon exposure to a chemical and/or irradiation and/or a range of temperature. The present invention also provides a reversibly modified oligonucleotide as described above, and a nucleic acid amplification reaction mixture and kit comprising such an oligonucleotide.
Abstract: The present invention relates to use of an antibacterial agent in the manufacture of a medicament for the treatment of osteoarthritis, more particularly for the treatment of a bacterial infection which is responsible for osteoarthritis. Also described are methods for the diagnosis of osteoarthritis through the detection of certain bacteria in an affected joint of a patient with osteoarthritis.
Abstract: The present invention provides methods, nucleic acids, compositions, and kits for detecting microRNA (miRNA) in samples. The methods comprise designing mRNA-specific primers, adding a polyA tail to the miRNA, and using reverse transcription and amplification to detect the miRNA. The nucleic acids, compositions, and kits typically comprise some or all of the components necessary to practice the methods of the invention.
Abstract: This invention provides combinations of novel oligonucleotides and their use in detecting a deletion(s) in the Pre-S region of HBV. Such a deletion(s) is associated with an increased risk of developing cirrhosis or hepatocellular carcinoma.
Type:
Grant
Filed:
June 9, 2009
Date of Patent:
October 23, 2012
Assignee:
National Health Research Institutes
Inventors:
Wenya Huang, Ih-Jen Su, Fang-Ching Shen
Abstract: A highly specific assay can be used for the detection of bacteremia in the clinical setting. The ubiquitous background endogenous DNA present in all PCR reagents is eliminated using a restriction endonuclease digestion. Universal primers for eubacteria are used for detection, and specific primers or probes for bacterial species can be used for identification of species.
Type:
Grant
Filed:
August 3, 2010
Date of Patent:
October 16, 2012
Assignee:
The Johns Hopkins University
Inventors:
Richard E. Rothman, Maulik D. Majmudar, Charlotte A. Gaydos
Abstract: The present invention provides methods for rapid forensic analysis of mitochondrial DNA and methods for characterizing heteroplasmy of mitochondrial DNA, which can be used to assess the progression of mitochondrial diseases.
Type:
Grant
Filed:
December 2, 2008
Date of Patent:
September 18, 2012
Assignee:
Ibis Biosciences, Inc.
Inventors:
David J. Ecker, Richard H. Griffey, Rangarajan Sampath, Stephen A. Hofstadler, John McNeil, Stanley T. Crooke, Lawrence B. Blyn, Thomas A. Hall, Yun Jiang, James C. Hannis, Neill White, Vivek Samant, Mark W. Eshoo, Jared J. Drader
Abstract: Compositions, methods, substrates and systems for use in analysis of single molecule reactions and particularly single molecule nucleic acid sequence analysis. Compositions that include non-reactive, distinguishable or undetectable competitive substrates for the reaction system of interest are provided, as well as their use in systems and substrates for such applications, such compounds typically preferably polyphosphate chains or analogous structures.
Type:
Grant
Filed:
February 12, 2009
Date of Patent:
August 28, 2012
Assignee:
Pacific Biosciences of California, Inc.
Inventors:
Keith Bjornson, Arek Bibillo, Lubomir Sebo
Abstract: This invention provides for compositions for use in real time nucleic acid detection processes. Such real time nucleic acid detection processes are carried out with energy transfer elements attached to nucleic acid primers, nucleotides, nucleic acid probes or nucleic acid binding agents. Real time nucleic acid detection allows for the qualitative or quantitative detection or determination of single-stranded or double-stranded nucleic acids of interest in a sample. Other processes are provided by this invention including processes for removing a portion of a homopolymeric sequence, e.g., poly A sequence or tail, from an analyte or library of analytes. Compositions useful in carrying out such removal processes are also described and provided.
Type:
Grant
Filed:
October 15, 2009
Date of Patent:
August 21, 2012
Assignee:
Enzo Life Sciences, Inc.
Inventors:
Elazar Rabbani, Jannis G. Stavrianopoulos, James J. Donegan, Jack Coleman, Dakai Liu
Abstract: A process for identifying a viral RNA nucleotide sequence present in a sample of peripheral blood cells which comprises amplifying such RNA simultaneously with at least one other RNA nucleotide sequence present in a virus infected cell in said sample, and thereafter separately and sequentially analyzing the amplification reaction products with probes homologous with authentic RNA and with such other RNA sequence to identify one or both of said RNA nucleotide sequences.
Type:
Grant
Filed:
September 1, 1989
Date of Patent:
July 24, 2012
Assignee:
City of Hope
Inventors:
George J. Murakawa, R. Bruce Wallace, John A. Zaia, John J. Rossi
Abstract: The present invention relates to a high sensitivity assay for molecular typing of a biological sample using surface-enhanced Raman scattering (SERS) including resonance scattering (SERRS); capture probes for capturing nucleic acid; a detector probe to detect captured nucleic acid; a kit for molecular typing of biological sample using surface-enhanced Raman scattering (SERS) including resonance scattering (SERRS); and lastly a method of manufacturing said kit.
Type:
Grant
Filed:
November 19, 2007
Date of Patent:
July 24, 2012
Assignees:
Jawaharlal Nehru Centre for Advanced Scientific Research, Microtest Innovations Pvt. Ltd.